CAS No.
[143-67-9 (Unlabeled)]
Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at freezer (-20°C) for long term storage
Synonyms
methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-(acetoxy-2-13C-d3)-3a-ethyl-9-((3R,5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
Refer MSDS for complete information
Vinblastine-13C,d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Vinblastine-13C,d3 usage and description
Vinblastine 13C D3 is a stable isotope-labeled derivative of Vinblastine, a medication used to treat several types of cancer. This compound is used in research and development as a tool for pharmacokinetic studies of Vinblastine. It is also used as an internal standard in mass spectrometry-based assays for the quantification of Vinblastine.
Vinblastine is an anti-cancer medication that works by binding to microtubules, which are structures that help cells divide. By binding to microtubules, Vinblastine interferes with cell division and ultimately leads to cell death. Vinblastine is primarily used to treat Hodgkin's disease, non-Hodgkin lymphoma, and testicular cancer.
Vinblastine 13C D3 is a labeled compound, meaning that it contains carbon atoms that have been replaced with heavier carbon-13 atoms. This labeling allows scientists to track the metabolism and distribution of Vinblastine in the body. Additionally, the labeling does not affect the pharmacological activity of the compound, meaning that it can be used as a reliable tool for research purposes.
In conclusion, Vinblastine 13C D3 is a useful tool for pharmacokinetic studies of Vinblastine and as an internal standard in mass spectrometry-based assays for the quantification of Vinblastine. Its chemical properties make it a reliable tool for research purposes without affecting the pharmacological activity of the compound.
